Search Results - "Brivio, E."

Regione Lombardia: a tool for improving quality in hospitals by Nobile, M, Luconi, E, Sfogliarini, R, Bersani, M, Brivio, E, Castaldi, S

“…The regional healthcare system of the Lombardy Region pay great attention to monitoring the effectiveness and quality level with which its services. The aim of…”
Get full text

Treatment of childhood acute lymphoblastic leukemia in central America: A lower-middle income countries experience by Navarrete, M., Rossi, E., Brivio, E., Carrillo, J.M., Bonilla, M., Vasquez, R., Peña, A., Fu, L., Martinez, R., Espinoza, C.M. Pacheco, Lacayo, L.F. Baez, Rodriguez, H., Batista, R., Barr, R., Howard, S.C., Ribeiro, R.C., Masera, G., Biondi, A., Conter, V., Valsecchi, M.G.

“…Background Five Asociación de Hemato‐Oncología de Centroamérica (AHOPCA) countries have used an adapted BFM‐based protocol for childhood acute lymphoblastic…”
Get full text

1498P Doctor-user communication on an online medical consulting platform: Analysis of user needs and representations of cancer treatments by Chichua, M., Brivio, E., Mazzoni, D., Monzani, D., Pravettoni, G.

Get full text

A bipolar disorder-associated missense variant alters adenylyl cyclase 2 activity and promotes mania-like behavior by Sen, Paromita, Ortiz, Oskar, Brivio, Elena, Menegaz, Danusa, Sotillos Elliott, Laura, Du, Ying, Ries, Clemens, Chen, Alon, Wurst, Wolfgang, Lopez, Juan Pablo, Eder, Matthias, Deussing, Jan M

“…The single nucleotide polymorphism rs13166360, causing a substitution of valine (Val) 147 to leucine (Leu) in the adenylyl cyclase 2 (ADCY2), has previously…”
Get full text

Prognostic Awareness in Terminally Ill Cancer Patients: A Narrative Literature Review of the Processes Involved by Chichua, Mariam, Mazzoni, Davide, Brivio, Eleonora, Pravettoni, Gabriella

“…High prognostic awareness (PA) is seen by many as a threat to terminal patients' psychological well-being. Whether this concern is supported by evidence or not…”
Get full text

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration by Pearson, Andrew D J, Zwaan, C Michel, Kolb, E Anders, Karres, Dominik, Guillot, Julie, Kim, Su Young, Marshall, Lynley, Tasian, Sarah K, Smith, Malcolm, Cooper, Todd, Adamson, Peter C, Barry, Elly, Benettaib, Bouchra, Binlich, Florence, Borgman, Anne, Brivio, Erica, Capdeville, Renaud, Delgado, David, Faller, Douglas, Fogelstrand, Linda, Fraenkel, Paula Goodman, Hasle, Henrik, Heenen, Delphine, Kaspers, Gertjan, Kieran, Mark, Klusmann, Jan-Henning, Lesa, Giovanni, Ligas, Franca, Mappa, Silvia, Mohamed, Hesham, Moore, Andrew, Morris, Joan, Nottage, Kerri, Reinhardt, Dirk, Scobie, Nicole, Simko, Stephen, Winkler, Thomas, Norga, Koen, Reaman, Gregory, Vassal, Gilles

“…The current standard-of-care for front-line therapy for acute myeloid leukaemia (AML) results in short-term and long-term toxicity, but still approximately 40%…”
Get full text

Sex shapes cell-type-specific transcriptional signatures of stress exposure in the mouse hypothalamus by Brivio, Elena, Kos, Aron, Ulivi, Alessandro Francesco, Karamihalev, Stoyo, Ressle, Andrea, Stoffel, Rainer, Hirsch, Dana, Stelzer, Gil, Schmidt, Mathias V., Lopez, Juan Pablo, Chen, Alon

“…Stress-related psychiatric disorders and the stress system show prominent differences between males and females, as well as strongly divergent transcriptional…”
Get full text

Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22 + acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial by Pennesi, Edoardo, Brivio, Erica, Ammerlaan, Anneke C J, Jiang, Yilin, Van der Velden, Vincent H J, Beverloo, H Berna, Sleight, Barbara, Locatelli, Franco, Brethon, Benoit, Rossig, Claudia, Engstler, Gernot, Nilsson, Anna, Bruno, Benedicte, Petit, Arnaud, Bielorai, Bella, Rizzari, Carmelo, Rialland, Fanny, Rubio-San-Simón, Alba, Sirvent, Francisco J Bautista, Diaz-de-Heredia, Cristina, Rives, Susana, Zwaan, Christian M

“…Inotuzumab ozogamicin (InO) is a CD22-directed antibody conjugated with calicheamicin. The phase IB of the ITCC-059 trial tested InO combined with chemotherapy…”
Get full text

Early life adversity shapes social subordination and cell type-specific transcriptomic patterning in the ventral hippocampus by Kos, Aron, Lopez, Juan Pablo, Bordes, Joeri, de Donno, Carlo, Dine, Julien, Brivio, Elena, Karamihalev, Stoyo, Luecken, Malte D, Almeida-Correa, Suellen, Gasperoni, Serena, Dick, Alec, Miranda, Lucas, Büttner, Maren, Stoffel, Rainer, Flachskamm, Cornelia, Theis, Fabian J, Schmidt, Mathias V, Chen, Alon

“…Adverse events in early life can modulate the response to additional stressors later in life and increase the risk of developing psychiatric disorders. The…”
Get full text

"Learning to live with cancer": Also an italian experience by Mazza, R., Murru, L., Brivio, E., Ferrario, R., Magri, M., Randazzo, F.

Get full text

Efficacy and difficulty in a program of home care for patients with cancer in an advanced stage by Brivio, E, Gamba, A

“…The difficulties experienced by nurses working in a service for domiciliary assistance have been studied through a series of three observations performed at…”
Get more information

Cancer immunotherapy with low-dose interleukin-2 subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant treatment with the pineal hormone melatonin by Lissoni, P, Barni, S, Ardizzoia, A, Olivini, G, Brivio, F, Tisi, E, Tancini, G, Characiejus, D, Kothari, L

“…The antitumor efficacy of IL-2 is limited to renal cancer and melanoma. Several cytokines have been associated with IL-2 in an attempt to improve its activity,…”
Get more information

A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors by Lissoni, P, Brivio, F, Fumagalli, L, Galimberti, C, Cataldo, M, Marsili, M T, Brivio, O, Barni, S, Tancini, G, Angelini, A

“…High levels of the macrophage activation marker neopterin have been described in metastatic cancer patients. Since macrophages may either counteract or…”
Get more information